Sage Therapeutics Inc Equity-NMS: SAGE

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :	$4.91
Open :	$4.75
Today's high :	$5.13
Today's low :	$4.62
52W low :	$4.62
52W high :	$28.26
1Y :	-61.29%
5Y :	-94.81%
EPS(TTM): :	-5.57
Shares O/S :	61.17 M
Market cap :	300.36 M

What is the share price of Sage Therapeutics Inc today?

Sage Therapeutics Inc (SAGE) share price as of September 5, 2024, is $7.64. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Sage Therapeutics Inc?

Yes, Indian Investors can invest in the Sage Therapeutics Inc (SAGE) Share by opening an international trading account with Angel One.

How can I purchase Sage Therapeutics Inc shares in India?

Purchasing Sage Therapeutics Inc (SAGE) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Sage Therapeutics Inc (SAGE) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Sage Therapeutics Inc?

Yes, you can purchase fractional shares of Sage Therapeutics Inc (SAGE) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Sage Therapeutics Inc?

The market capitalization of Sage Therapeutics Inc on September 5, 2024, is $462.15 M.

In which sector Sage Therapeutics Inc belongs?

Sage Therapeutics Inc operates in the Healthcare sector, specifically in the Biotechnology industry.

What documents are required to invest in Sage Therapeutics Inc stocks?

In order to invest in Sage Therapeutics Inc (SAGE) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Sage Therapeutics, Inc. is a biopharmaceutical company. The Company has developed the two FDA-approved treatments indicated for postpartum depression and is advancing a robust pipeline to target unmet needs in brain health. The Company is targeting diseases and disorders of the brain across its clinical development and earlier stage pipeline. Its product ZURZUVAE is for the treatment of postpartum depression (PPD) in adults. ZURZUVAE is a neuroactive steroid that is a positive allosteric modulator of GABA receptors, targeting both synaptic and extra synaptic GABA receptors. Its product ZULRESSO (brexanolone) CIV injection is for the treatment of PPD in individuals 15 years old and older. It is also developing a portfolio of other novel compounds that target GABA receptors, including SAGE-324, which is a novel GABAA receptor positive allosteric modulator intended for chronic oral dosing. Its second area of focus for development is novel compounds that target the NMDA receptor.